Related Experiment Videos
Implication of protein kinase C in IL-2-mediated proliferation and apoptosis in a murine T cell clone
J Gómez1, A de la Hera, A Silva
1Centro de Investigaciones Biológicas, Madrid, Spain.
Abstract:
Several reports have suggested that protein kinase C plays an essential role in T cell activation and apoptosis. The recent synthesis of the selective protein kinase C inhibitor, GF109203X, has made it possible to test the relevance of protein kinase C in T cell proliferation and apoptosis. We report that the use of GF109203X, in concentrations that are below its toxicity limits, inhibits IL-2-dependent proliferation in murine T cells expressing intermediate or high-affinity IL-2R (TS1 beta and TS1 alpha beta). In addition, GF109203X reverts the suppression of apoptosis mediated by IL-2 or IL-2+ dexamethasone. The use of the phorbol ester PMA, a protein kinase C activator, allows a bypass of the IL-2/IL-2R interaction in the suppression of apoptosis mediated by dexamethasone or IL-2 withdrawal in TS1 beta cells but not in TS1 alpha beta cells. Taken together, our data indicate that activation of protein kinase C is an important step in IL-2-mediated proliferation and in suppression of apoptosis.
Insights
Protein kinase C activation is crucial for T cell proliferation and preventing apoptosis. Inhibiting protein kinase C with GF109203X blocks IL-2-driven T cell growth and reverses apoptosis suppression.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Protein kinase C (PKC) is implicated in T cell activation and apoptosis.
- Selective PKC inhibitors like GF109203X enable functional studies.
- The role of PKC in IL-2 signaling and T cell fate requires further elucidation.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) in interleukin-2 (IL-2)-mediated T cell proliferation.
- To determine the effect of PKC inhibition on T cell apoptosis.
- To explore the interplay between PKC, IL-2 signaling, and apoptosis regulation.
Main Methods:
- Utilized the selective PKC inhibitor GF109203X in murine T cell lines (TS1 beta and TS1 alpha beta).
- Assessed IL-2-dependent proliferation and apoptosis.
- Employed phorbol ester (PMA) to activate PKC and bypass IL-2/IL-2R interactions.
Main Results:
- GF109203X significantly inhibited IL-2-dependent proliferation in T cells with intermediate or high-affinity IL-2 receptors.
- GF109203X treatment reversed the suppression of apoptosis induced by IL-2 or IL-2 plus dexamethasone.
- PMA partially rescued apoptosis suppression in TS1 beta cells, suggesting a role for PKC in this pathway.
Conclusions:
- PKC activation is a critical component of IL-2-mediated T cell proliferation.
- PKC plays a significant role in suppressing T cell apoptosis.
- Targeting PKC may offer therapeutic strategies for modulating T cell responses.